New Registry for Migraine Patients

May 8, 2018

Pharmaceutical Executive

The American Migraine Foundation (AMF) has developed a U.S. patient registry and biorepository for migraine. In collaboration with ZS, the AMF also has built a technology solution that sets out to collect a wide range of clinical and biological information from patients with migraine and other headache disorders, and to study that information over the course of an extended period of time.

The American Migraine Foundation (AMF) has developed a U.S. patient registry and biorepository for migraine. In collaboration with ZS, the AMF also has built a technology solution that sets out to collect a wide range of clinical and biological information from patients with migraine and other headache disorders, and to study that information over the course of an extended period of time.

AMF's American Registry for Migraine Research (ARMR) incorporates biological samples, leverages machine learning, and uses patient-reported outcomes, electronic health record and physician-captured data, and a mobile headache diary application to track the progress of patients over time.